Home›Stock Screener›Rossari Biotech

Rossari Biotech Share Price Today | Stock Price & Rossari Biotech Share Screener

ROSSARI Chemicals & Petrochemicals
Live Share Price NSE
₹428.00
▼ -4.75 (-1.10%)
2026-11-19 00:00:00
Live Share Price BSE
₹427.75
▼ -3.55 (-0.82%)
2026-11-19 00:00:00

As of November 19, 2026, the live Rossari Biotech share price (NSE: ROSSARI) is ₹428.00 on NSE and ₹427.75 on BSE, down 1.10% from the previous close, with shares trading between ₹425.00 and ₹433.95 in today's trading session, and a 52-week range of ₹378.60–₹614.35. Track ROSSARI market cap trends to gauge the company's total market size. Use the Rossari Biotech stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Rossari Biotech opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹704 and net income of ₹46, with EBITDA of ₹97, an operating margin of 11.0% and a profit margin of 6.5%.

Rossari Biotech Market Cap ₹2,398.01 Cr.
ROSSARI P/E Ratio (TTM) 15.50
Rossari Biotech P/B Ratio 1.68
EPS (TTM) ₹26.95
Dividend Yield 0.12%
Debt to Equity 0.26
ROSSARI 52 Week High ₹614.35
Rossari Biotech 52 Week Low ₹378.60
Operating Margin 11.00%
Profit Margin 6.53%
ROSSARI Revenue (TTM) ₹704.00
EBITDA ₹97.00
Net Income ₹46.00
Total Assets ₹2,289.00
Total Equity ₹1,333.00

Rossari Biotech Share Price Chart

Track the current stock price of Rossari Biotech with an interactive chart. Analyse ROSSARI share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Rossari Biotech stock quote in one place.

The quote of ₹428.00 sits between the 52-week low of ₹378.60 and the 52-week high of ₹614.35, and the latest session moved -1.10% from the previous close.

Rossari Biotech Company Profile - Fundamental Screener

Screen Rossari Biotech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ROSSARI shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Chemicals sector and the Chemicals & Petrochemicals industry, and it trades under ISIN INE02A801020.

Company Details

Classification

Sector Chemicals
Industry Chemicals & Petrochemicals
Sub-Sector Chemicals & Petrochemicals
Segment E

Identifiers and Leadership

ISIN INE02A801020

Rossari Biotech Balance Sheet Screener

Screen ROSSARI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹2,289, up from ₹1,896 in 2025.

Latest statistics put total assets at ₹2,289 and shareholder funds at ₹1,333, with a leverage ratio of 0.26.

Item 2026 2025 2024 2023 2022 2021 2020 2019

Assets

Total Assets 2,289 1,896 1,572 1,368 1,257 561 472 250
Current Assets 0 0 0 0 0 0 0 0
Fixed Assets 785 598 578 585 607 181 94 74

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0
Current Liabilities 166 174 100 104 157 2 36 4
Non-Current Liabilities 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 1,333 1,185 1,048 915 805 409 287 124
Share Capital 11 11 11 11 11 10 10 4
Reserves & Surplus 1,322 1,174 1,037 904 794 398 277 119

Rossari Biotech Income Statement Screener - Profit & Revenue Analysis

Screen Rossari Biotech income statement and profit fundamentals. Analyze ROSSARI quarterly results. Rossari Biotech reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹704 and net profit was ₹46, equal to earnings per unit of ₹8.30, at an operating margin of 11%.

In that period expenses were ₹608, interest cost ₹9 and tax ₹18. The next period listed, 2026-Jun, shows revenue of ₹701 and net profit of ₹35.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec

Revenue and Expenses

Revenue 704 701 699 582 545 588 583 473 491 499 514 410 413 485 467
Expenses 608 617 611 510 476 514 513 409 425 432 448 352 353 420 400

Operating Costs and Margins

EBITDA 97 84 88 71 70 74 70 64 66 67 66 58 60 65 67
Operating Profit % 11.00% 12.00% 12.00% 12.00% 12.00% 12.00% 12.00% 13.00% 13.00% 13.00% 13.00% 13.00% 14.00% 13.00% 14.00%
Depreciation 24 26 30 18 18 18 20 16 15 15 18 16 14 15 15
Interest 9 11 9 6 6 6 8 3 4 4 5 4 6 5 4

Profit and Earnings

Profit Before Tax 64 48 49 48 46 50 43 46 47 48 42 37 40 45 48
Tax 18 13 10 13 13 13 10 11 12 13 11 8 10 12 13
Net Profit 46 35 39 34 34 37 33 34 35 35 32 29 29 33 34
EPS 8.30 6.34 7.02 6.22 6.07 6.66 5.92 6.18 6.32 6.39 5.73 5.25 5.30 5.97 6.23

Rossari Biotech Cash Flow Screener - Liquidity Fundamentals

Screen ROSSARI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹65, and net cash flow was an inflow of ₹31.

Over the same period, investing activities used ₹220 and financing activities provided ₹186.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March

Cash from Operations and Investing

Operating Activities 65 137 43 152 29 48 57 71
Investing Activities -220 -183 -104 -181 -299 -37 -190 -37

Financing and Net Cash

Financing Activities 186 65 16 61 292 -25 157 -29
Net Cash Flow 31 19 -44 32 22 -14 24 5

Rossari Biotech Shareholding Pattern Screener

See Rossari Biotech shareholding pattern with promoter, FII, and DII holdings. Check Rossari Biotech promoter holding and ownership changes for ROSSARI on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 68.15%, foreign institutions 2.18%, domestic institutions 18.20% and the public 10.11%, spread across 86,972 shareholders.

The shareholder count was 86,972 in 2026-Mar, compared with 87,580 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 68.15% 68.14% 68.14% 68.18% 68.17% 68.17% 68.16% 68.32%

Institutional Investors

FII Holding 2.18% 2.02% 1.84% 3.98% 3.48% 2.69% 2.33% 4.03%
DII Holding 18.20% 14.64% 14.19% 17.59% 17.84% 18.18% 18.26% 17.75%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 10.11% 13.39% 13.79% 9.20% 9.44% 9.47% 9.89% 9.14%
Other Holding 1.35% 1.80% 2.04% 1.05% 1.07% 1.48% 1.37% 0.76%
Shareholder Count 86,972 87,580 86,622 92,852 91,791 91,387 89,249 98,859

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Rossari Biotech. Rossari Biotech dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.50 per unit for 2026-March, a yield of 0.12%, compared with ₹0.50 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.50, ₹0.50 and ₹0.50 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.50 0.12%
2025-March ₹0.50 0.13%
2024-March ₹0.50 0.08%
2023-March ₹0.50 0.07%
2022-March ₹0.50 0.08%
2021-March ₹0.50 0.05%
2020-March ₹0.50 0.05%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Rossari Biotech Stock Index Membership - Nifty & Sensex

See which indices include Rossari Biotech stock. Check ROSSARI index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 5 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX CARBON, BSE INDEX SMLCAP, NIFTY MICROCAP250.

Complete Index List

BSE 1000
BSE INDEX CARBON
BSE INDEX SMLCAP
NIFTY MICROCAP250
NIFTY TOTAL MKT

Rossari Biotech Market Events Screener - Corporate Actions

Get Rossari Biotech corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Rossari Biotech stock events that may affect ROSSARI share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated October 17, 2026, with a record date of October 17, 2026.

It is followed by Annual General Meeting dated July 20, 2026 and Quarterly Result Announcement dated July 18, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-10-17 2026-10-17 Quarterly Result Announcement NA 10.94%
2026-07-20 2026-07-20 Annual General Meeting NA 3.56%
2026-07-18 2026-07-18 Quarterly Result Announcement NA 2.49%
2026-07-10 2026-07-10 Dividend ₹ 0.50 /share 0.27%
2026-04-27 2026-04-27 Quarterly Result Announcement NA 2.48%
2026-01-17 2026-01-17 Quarterly Result Announcement NA -5.38%
2025-10-15 2025-10-15 Quarterly Result Announcement NA 2.97%
2025-07-19 2025-07-19 Quarterly Result Announcement NA 6.09%
2025-06-30 2025-06-30 Annual General Meeting NA 2.20%
2025-06-20 2025-06-20 Dividend ₹ 0.50 /share -5.99%
2025-04-25 2025-04-25 Quarterly Result Announcement NA 2.48%
2025-01-21 2025-01-21 Quarterly Result Announcement NA -0.71%
2024-11-11 2024-11-11 Extraordinary General Meeting NA -6.62%
2024-10-19 2024-10-19 Quarterly Result Announcement NA 2.55%
2024-08-23 2024-08-23 Annual General Meeting NA 13.57%

Rossari Biotech Competitors Screener - Peer Stocks Comparison

Screen ROSSARI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Chemicals sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Solar Industries 169,796 72.90 9,966 30.94% 1,737 44.30
Pidilite Industries 156,204 57.90 14,867 11.05% 2,471 51.75
SRF 73,496 32.00 15,894 7.20% 1,835 54.59
Linde 58,727 119.30 2,549 -0.17% 549 69.67
Gujarat Fluorochemicals 52,201 80.20 5,126 5.63% 574 58.95
Navin Fluorine International 50,343 55.60 3,379 41.21% 664 69.89
Himadri Speciality Chemical 28,319 32.20 4,832 3.60% 755 44.85
Aether Industries 22,069 87.10 1,181 34.17% 220 55.95
Deepak Nitrite 21,688 20.50 7,947 -5.01% 551 54.64
Deepak Fertilisers & Petrochemicals 18,225 14.70 11,609 12.11% 739 70.36

Rossari Biotech Company Announcements - News & Reports Screener

Screen ROSSARI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 22, 2026.

The next most recent announcements are dated October 19, 2026 and October 19, 2026.

Date Update Actions
2026-10-22 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-10-19 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-10-19 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-10-19 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-10-18 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-10-17 Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30 2026. -
2026-10-17 Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-10-17 Board Meeting Outcome for Board Meeting Outcome For Board Meeting Held On October 17 2026 -
2026-10-14 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-10-09 Board Meeting Intimation for Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended September 30 2026. -
2026-10-06 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-09-25 Closure of Trading Window -
2026-09-16 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-10 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-08-06 Update On Investor Call. -
2026-08-03 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-07-24 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-07-20 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-07-20 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-07-20 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹428.00, within a 52-week range of ₹378.60 to ₹614.35. The P/E ratio is 15.50 and the P/B ratio is 1.68, with earnings per unit of ₹26.95. Market capitalisation stands at ₹2,398.01 Cr and the dividend yield is 0.12%. The company operates in the Chemicals sector, in the Chemicals & Petrochemicals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 20, 2026. This page covers 8 balance sheet periods, 15 income statement periods, 8 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.